liver cancer
Conditions
Interventions
Experimental Group:B7H3-IRDye800CW
Sponsors
Dazhou Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Patients who meet the criteria of the "Primary Liver Cancer Diagnosis and Treatment Guidelines (2019 Edition)" and are clinically diagnosed with primary liver cancer; 2) Patients who are clinically diagnosed with primary liver cancer and are ready for open liver cancer surgery (including radical resection and tumor reduction) based on preoperative imaging and laboratory tests. Patients who are not suitable for surgery or who are unwilling to undergo laparoscopic liver cancer resection; 3) Child-Pugh A liver function; 4) Aged 18 to 80 years old, regardless of gender; 5) Voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who have used ICG or other fluorescent dyes; 2) Patients who are allergic to iodine; 3) Patients who have participated in other clinical trials within 3 months; 4) Patients who are considered unsuitable for inclusion by the researchers; 5) Patients whose systemic and organ conditions are considered to be difficult to tolerate liver cancer resection due to preoperative evaluation; 6) Patients or guardians who are unwilling or unable to provide written informed consent or do not comply with follow-up requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| operation time;The bleeding;Rate of R0 cut edge;progression-free survival;Overall Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative ALT and AST levels;Hospital stays;Hospital costs;Incidence of adverse events; | — |
Countries
China
Contacts
Public ContactJie Liu
Dazhou Central Hospital, Dazhou City, Sichuan Province
Outcome results
None listed